Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively 'Exon 10' isoforms

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 1243-1249

  Sergeant, N ^a,b   Wattez, A ^a   Delacourte, A ^a  

^a INSERM   (France)

^b School of Biological Sciences Derby Building   (United Kingdom)

Author keywords

Alzheimer disease; Antibodies; Corticobasal degeneration; Neurofibrillary degeneration; Progressive supranuclear palsy; Tau gene; Tau proteins

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PHOSPHORYLATION; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; BASAL GANGLIA; BLOTTING, WESTERN; CEREBRAL CORTEX; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXONS; HUMANS; ISOMERISM; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0033009603     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721243.x     Document Type: Article

References (25)

1. Bierer L. M., Hof P. R., Purohit D. P., Carlin L., Schmeidler J., Davis K. L., and Perl D. P. (1995) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52, 81-88.
2. Buée-Scherrer V., Condamine O., Mourton-Gilles C., Jakes R., Goedert M., Pau B., and Delacourte A. (1996a) AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol. Brain Res. 39, 79-88.
3. Buée-Scherrer V., Hof P. R., Buée L., Leveugle B., Vermersch P., Perl D. P., Olanow C. W., and Delacourte A. (1996b) Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol. 91, 351-359.
4. Conrad C., Andreadis A., Trojanowski J. Q., Dickson D. W., Kang D., Chen X. H., Wiederholt W., Hansen L., Masliah E., Thal L. J., Katzman R., Xia Y., and Saitoh T. (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41, 277-281.
5. Delacourte A. and Buée L. (1997) Normal and pathological Tau proteins as factors for microtubule assembly. Int. Rev. Cytol. 171, 167-224.
6. Delacourte A., Sergeant N., Robitaille Y., Buée-Scherrer V., Buée L., David J.-P., Bussiére T., Vermersch P., Hof P. R., Gauvreau D., and Wattez A. (1997) Pathological Tau proteins are biochemical markers that differentiate several types of neurofibrillary degeneration, in Biology, Diagnosis and Therapeutics (Iqbal K., Winblad B., Nishimura T., Takeda M., and Wisniewski H., eds), pp. 205-212. John Wiley & Sons Ltd., Chichester.
7. Delacourte A., Sergeant N., Wattez A., Gauvreau D., and Robitaille Y. (1998a) Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann. Neurol. 43, 193-204.
8. Delacourte A., Buée L., David J.-P., Sergeant N., Wattez A., Vermersch P., Pasquier F., Leben F., Ghozali F., Fallet-Bianco C., and DiMenza C. (1998b) Lack of continuum between cerebral aging and Alzheimer's disease, as revealed by PHF-Tau and Abeta biochemistry. Alzheimers Rep. 1, 101-110.
9. Duyckaerts C., Bennecib M., Grignon Y., Uchihara T., He Y., Piette F., and Hauw J.-J. (1997) Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol. Aging 18, 267-273.
10. Flament S., Delacourte A., Verny M., Hauw J.-J., and Javoy-Agid F. (1991) Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrilary degeneration of the Alzheimer type. Acta Neuropathol. 81, 591-596.
11. Goedert M., Spillantini M. G., Cairns N. J., and Crowther R. A. (1992) Tau-proteins of Alzheimer paired helical filaments - abnormal phosphorylalion of all six brain isoforms. Neuron 8, 159-168.
12. Goedert M., Spillantini M. G., Jakes R., Crowther R. A., Vanmechelen E., Probst A., Gotz, J., Burki K., and Cohen P. (1995) Molecular dissection of the paired helical filament. Neurobiol. Aging 16, 325-334.
13. Hof P. R., Bouras C., Perl D. P., and Morrison J. H. (1994) Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol. (Berl.) 87, 115-124.
14. Hoffmann R., Lee V. M.-Y., Leight S., Varga I., and Otvos L. Jr. (1997) Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 36, 8114-8124.
15. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R. C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J. M., Nowotny P., Heutink P., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
16. Kertesz A. and Munoz D. (1996) Clinical and pathological characteristics of primary progressive aphasia and frontal dementia. J. Neural Transm. Suppl. 47, 133-141.
17. Litvan I., Campbell G., Mangone C. A., Verny M., McKee A., Chaudhuri K. R., Jellinger K., Pearce R. K. B., and Dolhaberriague L. (1997a) Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 120, 65-74.
18. Litvan I., Agid Y., Goetz C., Jankovic J., Wenning G. K., Brandel J. P., Lai E. C., Verny M., Ray-Chaudhuri K., McKee A., Jellinger K., Pearce R. K. B., and Bartko J. J. (1997b) Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48, 119-125.
19. Murrell J. R., Koller D., Foroud T., Goedert M., Spillantini M. G., Edenberg H. J., Farlow M. R., and Ghetti B. (1997) Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17. Am. J. Hum. Genet. 61, 1131-1138.
20. Panda D., Goode B. L., Feinstein S. C., and Wilson L. (1995) Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau. Biochemistry 34, 11117-11127.
21. Schmidt M. L., Huang R., Martin J. A., Henley J., Mawal-Dewan M., Hurtig H. I., Lee V. M., and Trojanowski J. Q. (1996) Neurofibrillary tangles in progressive supranucleur palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J. Neuropathol. Exp. Neurol. 55, 534-539.
22. Sergeant N., David J.-P., Goedert M., Jakes R., Vermersch P., Buée L., Lefranc D., Wattez A., and Delacourte A. (1997) Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications. J. Neurochem. 69, 834-844.
23. Seubert P., Mawal-Dewan M., Barbour R., Jakes R., Goedert M., Johnson G. V. W., Litersky J. M., Schenk D., Lieberburg I., Trojanowski J. Q., and Lee V. M.-Y. (1995) Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem. 270, 18917-18922.
24. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A., and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad Sci. USA 95, 7737-7741.
25. Vermersch P., Robitaille Y., Bernier L., Wattez A., Gauvreau D., and Delacourte A. (1994) Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol. (Berl.) 87, 572-577.